The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Source: https://www.cnbc.com/2024/04/26/fda-app ... lia-b.html
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
